By the seaside of Manila, Pluslife is making waves at the Medical Philippines Expo 2023, the final chapter of its exhibition journey across Southeast Asia. From the latest Point-of-Care (POC) molecular analyzers to an extensive test menu. Served as a hub of next-generation Point-of-Care Testing (POCT) technologies at Booth No. 7, visitors are presented with in-depth knowledge of how Pluslife’s products are set to revolutionize infectious disease management at the primary care level from August 23 to 25.

The Medical Philippines Expo, also known as PhilMedical, is the most complete and specialized medical technology event in the Philippines — the third-largest pharmaceutical market in ASEAN. This dynamic expo brings together a global assembly of various medical industry principals to unveil the latest advancements and technologies in the healthcare sector.

Pluslife’s isothermal amplification method, the self-developed, patented technology RNase Hybridization Assisted Amplification (RHAM) has captured broad attention. This groundbreaking technology serves as a driving force behind Pluslife's products, and its self-invented optimized enzymes achieve faster amplification speed and stronger resistance to inhibitors. Combined with our core protein and enzyme engineering platform, Pluslife remains steadfast in its commitment to advancing the industrialization of molecular POCT products.

Pluslife molecular POCT is ideally tailored for application in community-based healthcare facilities. Based on the in-house raw materials platforms and production lines, Pluslife molecular POCT products show a strong cost advantage over similar products, improving cost efficiency and overall economic value. Requiring just four straightforward hands-on steps, Pluslife's tests are user-friendly, making them well-suited for operation at the primary care level and within remote healthcare settings where access to professional personnel and laboratory infrastructures is limited.

Pluslife is dedicated to providing cost-effective, rapid, and robust molecular POCT solutions to the ASEAN market, strengthening the region's capabilities in effectively managing and preventing infectious diseases. We're excited to announce our participation in the upcoming IBMS Biomedical Science Congress in Birmingham, scheduled from September 25 to 28.